Cancer Genetics, Inc. - Product Pipeline Analysis

1
Cancer Genetics, Inc. - Product Pipeline
AnalysisMarket Research Reports Distributor
- Aarkstore.com have vast database on market
research reports, company financials, company
profiles, SWOT analysis, company report, company
statistics, strategy review, industry report,
industry research to provide excellent and
innovative service to our report
buyers.Aarkstore.com have very interactive
search feature to browse across more than
2,50,000 business industry reports. We are built
on the premise that reading is valuable, capable
of stirring emotions and firing the imagination.
Whether you're looking for new market research
report product trends or competitive industry
analysis of a new or existing market,
Aarkstore.com has the best resource offerings and
the expertise to make sure you get the right
product every time.
2
Cancer Genetics, Inc. - Product Pipeline Analysis

• SummaryCancer Genetics, Inc. (CGI) is the
  leader in the field of personalized medicine. It
  offers cancer diagnostics and treatments
  tailoring the specific genetic profile of the
  individual. The diagnostic assays and products
  offered by the company are designed to increase
  treatment efficacy and reduce healthcare costs of
  the hematological, urogenital and HPV-associated
  cancers. The products offered by the company
  include DNA-FISH Probes, CGH Microarrays and
  Next-Generation Sequencing. The products under
  development include FISH Probes for the diagnosis
  of renal cancer, HPV-associated cancer test and
  Microarrays for the diagnosis of leukamia,
  ovarian cancer, cervical cancer, bladder cancer,
  prostate cancer amongst others. The company also
  offers comprehensive array of integrated
  laboratory services for the diagnosis of cancer.
  CGI is headquartered in New Jersey, the US.This
  report is a source for data, analysis and
  actionable intelligence on the Cancer Genetics,
  Inc. portfolio of pipeline products. The report
  provides detailed analysis on each pipeline
  product with information on the indication, the
  development stage, trial phase, product
  milestones, pipeline territory, estimated
  approval date, and estimated launch dateEach
  pipeline product is profiled to cover information
  on product description, function, technology,
  indication, and application. The report is also
  supplemented with a detailed company profile and
  information on clinical trials, wherever
  applicable.This report is built using data and
  information sourced from proprietary databases,
  primary and secondary research and in-house
  analysis by GlobalDatas team of industry
  experts.
• Scope- Detailed company profile with
  information on business description, key company
  facts, major products and services, key
  competitors, key employees, locations and
  subsidiaries and recent developments.- Detailed
  coverage on all the pipeline products, by
  equipment type, by therapy area, by development
  stage, and by trial phase.- Information on
  product milestones and pipeline territory for
  each product, the estimated approval date, and
  estimated launch date.

3

• - Profile of each pipeline product with
  additional information on product description,
  function, technology, indication(s), and
  application.- Data on relevant clinical trials
  and product patent details, wherever
  applicable.- Information on clinical trial,
  wherever applicable, is supplemented with
  information on trial phase, trial status, trial
  objective, trial design, target patients, unique
  physician identifier, primary point, secondary
  point, acronym, participants inclusion,
  participants exclusion, interventions, trial
  results, trial start date, trial end date, study
  type, trial site, trial funding, age eligibility,
  and gender eligibility.
• Reasons to Buy- Develop business strategies by
  understanding the trends and developments driving
  the medical devices pipeline and technology
  landscape globally.- Design and develop your
  product development, marketing and sales
  strategies.- Exploit MA opportunities by
  identifying market players with the most
  innovative pipeline.- Develop market-entry and
  market expansion strategies.- Exploit
  in-licensing and out-licensing opportunities by
  identifying products, most likely to ensure a
  robust return.- Identify emerging players with
  potentially strong product portfolio and create
  effective counter-strategies to gain competitive
  advantage.- Develop competition strategies by
  identifying the status and likely launch of your
  competitors pipeline products through review of
  the clinical trials, stage and phase of
  development, etc.- Which are the next high-value
  products that your competitor would add in its
  portfolio? identify, understand and capitalize.

4

• List of Tables 4List of Figures 5Key Facts
  6Cancer Genetics, Inc. - Major Products and
  Services 7Cancer Genetics, Inc. Pipeline
  Products by Equipment Type 8Cancer Genetics,
  Inc. Pipeline Products by Development Stage
  10Cancer Genetics, Inc. Pipeline Products by
  Therapy Area 12FHACT HPV - Associated Cancer
  Test 14FHACT HPV - Associated Cancer Test
  Product Status 14FHACT HPV - Associated Cancer
  Test Product Description 14FReCaD Renal Cancer
  Test 15FReCaD Renal Cancer Test Product Status
  15FReCaD Renal Cancer Test Product Description
  15LeukA - Leukemia 16LeukA - Leukemia Product
  Status 16LeukA - Leukemia Product Description
  16MatBA Diagnostic Test - Diffuse Large B-cell
  Lymphoma 17MatBA Diagnostic Test - Diffuse Large
  B-cell Lymphoma Product Status 17MatBA
  Diagnostic Test - Diffuse Large B-cell Lymphoma
  Product Description 17MatBA Diagnostic Test -
  Diffuse Large B-cell Lymphoma Product Patent
  Details 17MatBA Diagnostic Test - Follicular
  Lymphoma 19MatBA Diagnostic Test - Follicular
  Lymphoma Product Status 19MatBA Diagnostic Test
  - Follicular Lymphoma Product Description
  19MatBA Diagnostic Test - Follicular Lymphoma
  Product Patent Details 19MatBA Diagnostic Test -
  Mantle Cell Lymphoma 21MatBA Diagnostic Test -
  Mantle Cell Lymphoma Product Status 21MatBA
  Diagnostic Test - Mantle Cell Lymphoma Product
  Description 21MatBA Diagnostic Test - Mantle
  Cell Lymphoma Product Patent Details 21MatBA
  Diagnostic Test - Marginal Zone Lymphoma 23MatBA
  Diagnostic Test - Marginal Zone Lymphoma Product
  Status 23MatBA Diagnostic Test - Marginal Zone
  Lymphoma Product Description 23MatBA Diagnostic
  Test - Marginal Zone Lymphoma Product Patent
  Details 23MatBA Diagnostic Test - Multiple
  Myeloma 25MatBA Diagnostic Test - Multiple
  Myeloma Product Status 25MatBA Diagnostic Test -
  Multiple Myeloma Product Description 25MatBA
  Diagnostic Test - Multiple Myeloma Product Patent
  Details 25

5

• UGenRA - Cervix 27UGenRA - Cervix
  Product Status 27UGenRA - Cervix Product
  Description 27UGenRA - Endometrium 28UGenRA -
  Endometrium Product Status 28UGenRA -
  Endometrium Product Description 28UGenRA - Ovary
  29UGenRA - Ovary Product Status 29UGenRA -
  Ovary Product Description 29UroGenRA - Bladder
  30UroGenRA - Bladder Product Status 30UroGenRA
  - Bladder Product Description 30UroGenRA -
  Kidney 31UroGenRA - Kidney Product Status
  31UroGenRA - Kidney Product Description
  31UroGenRA - Prostate 32UroGenRA - Prostate
  Product Status 32UroGenRA - Prostate Product
  Description 32Cancer Genetics, Inc. - Key
  Competitors 33Cancer Genetics, Inc. - Key
  Employees 34Cancer Genetics, Inc. - Locations
  And Subsidiaries 35Head Office 35Recent
  Developments 36Cancer Genetics, Inc., Recent
  Developments 36Aug 02, 2012 Roche Servicios
  Selects Cancer Genetics For Diagnosis And
  Personalization Of Oncology Treatment 36Mar 23,
  2011 Cancer Genetics And Aptiv Solutions Partner
  To Create More Effective Clinical Trials In
  Oncology 36Appendix 37Methodology 37About
  GlobalData 37Contact Us 37Disclaimer 37  

6

List of Tables Cancer Genetics, Inc., Key
Facts 1Cancer Genetics, Inc. Key Pipeline
Products by Equipment Type 1Cancer Genetics,
Inc. Key Pipeline Products by Therapy Area
1Cancer Genetics, Inc. Key Pipeline Products by
Development Stage 1Cancer Genetics, Inc., Key
Facts 6Cancer Genetics, Inc., Major Products and
Services 7Cancer Genetics, Inc. Number of
Pipeline Products by Equipment Type 8Cancer
Genetics, Inc. Pipeline Products by Equipment
Type 9Cancer Genetics, Inc. Number of Pipeline
Products by Development Stage 10Cancer Genetics,
Inc. Pipeline Products by Development Stage
11Cancer Genetics, Inc. Number of Pipeline
Products by Therapy Area 12Cancer Genetics, Inc.
Pipeline Products by Therapy Area 13FHACT HPV -
Associated Cancer Test - Product Status 14FHACT
HPV - Associated Cancer Test - Product
Description 14FReCaD Renal Cancer Test - Product
Status 15FReCaD Renal Cancer Test - Product
Description 15LeukA - Leukemia - Product Status
16LeukA - Leukemia - Product Description
16MatBA Diagnostic Test - Diffuse Large B-cell
Lymphoma - Product Status 17MatBA Diagnostic
Test - Diffuse Large B-cell Lymphoma - Product
Description 17MatBA Diagnostic Test - Diffuse
Large B-cell Lymphoma - Patent Details1 17MatBA
Diagnostic Test - Follicular Lymphoma - Product
Status 19MatBA Diagnostic Test - Follicular
Lymphoma - Product Description 19MatBA
Diagnostic Test - Follicular Lymphoma - Patent
Details1 19MatBA Diagnostic Test - Mantle Cell
Lymphoma - Product Status 21MatBA Diagnostic
Test - Mantle Cell Lymphoma - Product Description
21MatBA Diagnostic Test - Mantle Cell Lymphoma -
Patent Details1 21MatBA Diagnostic Test -
Marginal Zone Lymphoma - Product Status 23MatBA
Diagnostic Test - Marginal Zone Lymphoma -
Product Description 23MatBA Diagnostic Test -
Marginal Zone Lymphoma - Patent Details1 23MatBA
Diagnostic Test - Multiple Myeloma - Product
Status 25MatBA Diagnostic Test - Multiple
Myeloma - Product Description 25
7
MatBA Diagnostic Test - Multiple Myeloma -
Patent Details1 25UGenRA - Cervix - Product
Status 27UGenRA - Cervix - Product Description
27UGenRA - Endometrium - Product Status
28UGenRA - Endometrium - Product Description
28UGenRA - Ovary - Product Status 29UGenRA -
Ovary - Product Description 29UroGenRA - Bladder
- Product Status 30UroGenRA - Bladder - Product
Description 30UroGenRA - Kidney - Product Status
31UroGenRA - Kidney - Product Description
31UroGenRA - Prostate - Product Status
32UroGenRA - Prostate - Product Description
32Cancer Genetics, Inc., Key Employees 34 List
of Figures Cancer Genetics, Inc. Pipeline
Products by Equipment Type 8Cancer Genetics,
Inc. Pipeline Products by Development Stage
10Cancer Genetics, Inc. Pipeline Products by
Therapy Area 12  
8
Related Reports

• OptiMedica Corporation - Medical Equipment -
  Deals and Alliances Profile
• SuperSonic Imagine, SA - Medical Equipment -
  Deals and Alliances Profile
• MDwerks, Inc. (MDWK) - Medical Equipment - Deals
  and Alliances Profile
• Andover Medical, Inc. (ADOV) - Medical Equipment
  - Deals and Alliances Profile
• Certified Diabetic Services, Inc. - Medical
  Equipment - Deals and Alliances Profile
• Confirma Inc. - Medical Equipment - Deals and
  Alliances Profile
• SQI Diagnostics Inc. (SQD) - Medical Equipment -
  Deals and Alliances Profile
• Coapt Systems, Inc. - Medical Equipment - Deals
  and Alliances Profile
• VertiFlex Inc. - Medical Equipment - Deals and
  Alliances Profile
• Competitive Intelligence Leading Coagulation
  Market Players--Strategic Assessments of Major
  Suppliers and Emerging Market Entrants

9

• Contact Us
• Aarkstore Enterprise
• Tel [phone]
• Mobile No08149852585
• Email contact_at_aarkstore.com
• Website http//www.aarkstore.com
• Blog http//www.emarketreports.com
• http//teju-aarkstoreenterprise.blogspot.in
• Follow us on twitter http//twitter.com/aarkstore
  dotcom
• http//in.linkedin.com/in/aarkstore
• http//www.facebook.com/aarkstoreenterprise